Drägerwerk AG & Co. KGaA

DRW3

DE0005550636

Advanced Medical Equipment & Technology

Market Closed - Xetra Other stock markets 11:35:10 2024-04-23 am EDT			5-day change	1st Jan Change
50.8 ^EUR	0.00%		+0.40%	-1.93%

Apr. 16	DRÄGERWERK AG & CO KGAA : Silver lining beyond the soft Q124 headline figures
Apr. 16	DRAEGERWERK : Hauck & Aufhauser remains its Buy rating	ZD

DRAEGERWERK : Warburg Research reaffirms its Neutral rating

June 16, 2021 at 04:40 am EDT

Warburg Research analyst Eggert Kuls maintains his Neutral opinion on the stock. The target price is unchanged and still at EUR 84.20.

Latest news about Drägerwerk AG & Co. KGaA

DRÄGERWERK AG & CO KGAA : Silver lining beyond the soft Q124 headline figures	Apr. 16
DRAEGERWERK : Hauck & Aufhauser remains its Buy rating	Apr. 16	ZD
: Drägerwerk starts the year with lower sales - outlook confirmed	Apr. 16	DP
Jefferies rates Drägerwerk at 'Underperform' - Target 42 euros	Apr. 16	DP
DRAEGERWERK : Jefferies gives a Sell rating	Apr. 16	ZD
Roundup: Drägerwerk starts the year with lower sales - outlook confirmed	Apr. 15	DP
Drägerwerk starts the new year with a slight decline in sales	Apr. 15	DP
DRÄGERWERK AG & CO KGAA : EPS upgrade (2023: +14.2%, 2024: +3.8%)	Apr. 15
DRAEGERWERK : Hauck & Aufhauser reiterates its Buy rating	Mar. 22	ZD
DRÄGERWERK AG & CO KGAA : FY23: Dividend surprise holds centre-stage	Mar. 08
DRAEGERWERK : Hauck & Aufhauser gives a Buy rating	Mar. 08	ZD
Drägerwerk AG & Co. KGaA Provides Earnings Guidance for the Year 2024	Mar. 07	CI
Drägerwerk AG & Co. KGaA Increases Dividend for the Year 2023	Mar. 07	CI
Transcript : Drägerwerk AG & Co. KGaA, 2023 Earnings Call, Mar 07, 2024	Mar. 07
Drägerwerk AG & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
Drägerwerk to increase dividend more than expected - share price rises	Mar. 07	DP
Dpa-AFX Overview: COMPANIES from 07/03/2024 - 10:15 am	Mar. 07	DP
DRAEGERWERK : Hauck & Aufhauser keeps its Buy rating	Jan. 17	ZD
DRÄGERWERK AG & CO KGAA : Target upgrade by 10.1%	Jan. 17
DRÄGERWERK AG & CO KGAA : Strong finish to FY23; China the ‘swing factor’ in FY24	Jan. 16
Warburg Research rates Drägerwerk at 'Buy' - Target 62 euros	Jan. 16	DP
Dpa-AFX Overview: COMPANIES from 16.01.2024 - 15:15	Jan. 16	DP
DRAEGERWERK : Warburg Research reiterates its Buy rating	Jan. 16	ZD
DRAEGERWERK : Gets a Sell rating from Jefferies	Jan. 16	ZD
Drägerwerk expects more moderate growth - significantly higher dividend	Jan. 16	DP

Chart Drägerwerk AG & Co. KGaA

Duration

Period

More charts

Draegerwerk AG & Co KGaA is a Germany-based provider of medical and safety technology. The Company operates through two segments: Medical and Safety. The Medical segment develops, produces and markets system solutions, equipment and services for the optimization of processes at the acute point of care, such as emergency care, preoperative care, critical care and prenatal care. The Safety segment develops, produces and markets products, system solutions and services for personal protection, gas detection technology and integrated hazard management for customers from various industries, such as mining, fire departments, police and disaster protection. The Company has production sites in Europe, the Americas, Africa and Asia.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-04-25 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

DRÄGERWERK AG & CO KGAA : Silver lining beyond the soft Q124 headline figures

April 16, 2024 at 01:16 pm EDT

More Strategies

Ratings for Drägerwerk AG & Co. KGaA

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

50.8 EUR

Average target price

56.25 EUR

Spread / Average Target

+10.73%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
DRÄGERWERK AG & CO. KGAA	-1.93%	944M
THERMO FISHER SCIENTIFIC	+8.35%	209B
DANAHER CORPORATION	+9.41%	175B
INTUITIVE SURGICAL, INC.	+11.75%	131B
BOSTON SCIENTIFIC CORPORATION	+19.34%	99.98B
SIEMENS HEALTHINEERS AG	-0.84%	61.12B
EDWARDS LIFESCIENCES CORPORATION	+15.08%	52.34B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-2.10%	46.5B
AGILENT TECHNOLOGIES, INC.	+0.10%	39.24B
GE HEALTHCARE TECHNOLOGIES INC.	+11.50%	38.47B

Other Advanced Medical Equipment & Technology

Drägerwerk AG & Co. KGaA

Equities

DRW3

DE0005550636

Advanced Medical Equipment & Technology

DRAEGERWERK : Warburg Research reaffirms its Neutral rating

Latest news about Drägerwerk AG & Co. KGaA

Chart Drägerwerk AG & Co. KGaA

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Drägerwerk AG & Co. KGaA

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology